Contraception
Volume 82, Issue 1 , Pages 102-112 , July 2010

Contraceptive use among solid organ transplant patients: a systematic review

Received 3 February 2010 ,Accepted 4 February 2010.

References 

  1. Organ Procurement and Transplantation Network . Organ Procurement and Transplantation Network, HRSA, DHHS 9 A.D. November 10. Available from URL: http://optn.transplant.hrsa.gov/
  2. Watnick S, Rueda J. Reproduction and contraception after kidney transplantation. Curr Opin Obstet Gynecol. 2008;20:308–312
  3. First MR, Combs CA, Weiskittel P, Miodovnik M. Lack of effect of pregnancy on renal allograft survival or function. Transplantation. 1995;59:472–476
  4. Taylor RM, Franck LS, Gibson F, Dhawan A. Liver transplantation in children: part 2 — long-term issues. J Child Health Care. 2005;9:274–287
  5. Mass K, Quint EH, Punch MR, Merion RM. Gynecological and reproductive function after liver transplantation. Transplantation. 1996;62:476–479
  6. de Koning ND, Haagsma EB. Normalization of menstrual pattern after liver transplantation: consequences for contraception. Digestion. 1990;46:239–241
  7. Laifer SA, Guido RS. Reproductive function and outcome of pregnancy after liver transplantation in women. Mayo Clin Proc. 1995;70:388–394
  8. Watnick S. Pregnancy and contraceptive counseling of women with chronic kidney disease and kidney transplants. Adv Chronic Kidney Dis. 2007;14:126–131
  9. Karkar A. Pregnancy and contraceptive issues in renal transplant recipients. Saudi J Kidney Dis Transpl. 2008;19:165–173
  10. Davison JM, Bailey DJ. Pregnancy following renal transplantation. J Obstet Gynaecol Res. 2003;29:227–233
  11. Riely CA. Contraception and pregnancy after liver transplantation. Liver Transpl. 2001;7:S74–S76
  12. Armenti VT, Radomski JS, Moritz MJ, Philips LZ, McGrory CH, Coscia LA. Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. Clin Transpl. 2000;123–134
  13. Laifer SA, Darby MJ, Scantlebury VP, Harger JH, Caritis SN. Pregnancy and liver transplantation. Obstet Gynecol. 1990;76:1083–1088
  14. McKay DB, Josephson MA, Armenti VT, et al. Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant. 2005;5:1592–1599
  15. World Health Organization. Medical Eligibility Criteria for Contraceptive Use. World Health Organization 2008 December 1 [cited 2009 Jan 22];(4th edition).
  16. Mohllajee AP, Curtis KM, Flanagan RG, Rinehart W, Gaffield ML, Peterson HB. Keeping up with evidence: a new system for WHO's evidence-based family planning guidance. Am J Prev Med. 2005;28:483–490
  17. Harris RP, Helfand M, Woolf SH, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001;20:21–35
  18. Pietrzak B, Bobrowska K, Jabiry-Zieniewicz Z, et al. Oral and transdermal hormonal contraception in women after kidney transplantation. Transplant Proc. 2007;39:2759–2762
  19. Pietrzak B, Kaminski P, Wielgos M, Bobrowska K, Durlik M. Combined oral contraception in women after renal transplantation. Neuro Endocrinol Lett. 2006;27:679–682
  20. Fong YF, Singh K. Effect of the levonorgestrel-releasing intrauterine system on uterine myomas in a renal transplant patient. Contraception. 1999;60:51–53
  21. Zerner J, Doil KL, Drewry J, Leeber DA. Intrauterine contraceptive device failures in renal transplant patients. J Reprod Med. 1981;26:99–102
  22. Lessan-Pezeshki M, Ghazizadeh S, Khatami MR, et al. Fertility and contraceptive issues after kidney transplantation in women. Transplant Proc. 2004;36:1405–1406
  23. O'Donnell D. Contraception in the female transplant recipient. Dialysis Transplant 1986;15:610, 612.
  24. Jabiry-Zieniewicz Z, Bobrowska K, Kaminski P, Wielgos M, Zieniewicz K, Krawczyk M. Low-dose hormonal contraception after liver transplantation. Transplant Proc. 2007;39:1530–1532
  25. Fedorkow DM, Corenblum B, Shaffer EA. Cholestasis induced by oestrogen after liver transplantation. BMJ. 1989;299:1080–1081
  26. Mattix Kramer HJ, Tolkoff-Rubin NE, Williams WW, Cosimi AB, Pascual MA. Reproductive and contraceptive characteristics of premenopausal kidney transplant recipients. Prog Transplant. 2003;13:193–196
  27. Guazzelli CA, Torloni MR, Sanches TF, Barbieri M, Pestana JO. Contraceptive counseling and use among 197 female kidney transplant recipients. Transplantation. 2008;86:669–672
  28. Estes CM, Westhoff C. Contraception for the transplant patient. Semin Perinatol. 2007;31:372–377
  29. Gaston RS. Maintenance immunosuppression in the renal transplant recipient: an overview. Am J Kidney Dis. 2001;38:S25–S35
  30. Seidegard J, Simonsson M, Edsbacker S. Effect of an oral contraceptive on the plasma levels of budesonide and prednisolone and the influence on plasma cortisol. Clin Pharmacol Ther. 2000;67:373–381
  31. Ortiz ME, Croxatto HB. Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action. Contraception. 2007;75:S16–S30
  32. Stringer EM, Kaseba C, Levy J, et al. A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. Am J Obstet Gynecol. 2007;197:144–148
  33. Trussell J. Contraceptive efficacy. In:  Hatcher RA,  Trussell J,  Nelson AL,  Cates W,  Stewart FH,  Kowal D editor. Contraceptive technology: nineteenth revised edition. New York (NY): Ardent Media; 2007;p. 747–826
  34. Morrison CS, Sekadde-Kigondu C, Sinei SK, Weiner DH, Kwok C, Kokonya D. Is the intrauterine device appropriate contraception for HIV-1-infected women?. BJOG. 2001;108:784–790
  35. World Health Oranization . Medical eligibility criteria for contraceptive use. 3rd ed.. Geneva: World Health Organization; 2004;
  36. Kossoy LR, Herbert CM, Wentz AC. Management of heart transplant recipients: guidelines for the obstetrician-gynecologist. Am J Obstet Gynecol. 1988;159:490–499
  37. Mazziotti G, Angeli A, Bilezikian JP, Canalis E, Giustina A. Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol Metab. 2006;17:144–149
  38. Shaker JL, Lukert BP. Osteoporosis associated with excess glucocorticoids. Endocrinol Metab Clin North Am. 2005;34:341–ix
  39. Curtis KM, Martins SL. Progestogen-only contraception and bone mineral density: a systematic review. Contraception. 2006;73:470–487
  40. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 1998;9:S16–S23

☆ The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

PII: S0010-7824(10)00051-X

doi: 10.1016/j.contraception.2010.02.007

Contraception
Volume 82, Issue 1 , Pages 102-112 , July 2010

Article Tools